ANAL SQUAMOUS CELL CARCINOMA
Clinical trials for ANAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ANAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ANAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
MRI-Guided radiation tailors treatment for anal cancer patients
Disease control Recruiting nowThis phase 2 trial tests a new way to deliver radiation therapy for anal cancer using MRI guidance to adjust doses based on each patient's risk level. About 80 adults with anal squamous cell carcinoma will receive different radiation schedules depending on their tumor risk group.…
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New drug EVOLVE104 takes on tough cancers in early human trial
Disease control Recruiting nowThis early-stage trial is testing an experimental drug called EVOLVE104 in people with advanced bladder cancer or several types of squamous cell carcinoma (lung, esophagus, skin, and others). The study aims to find a safe dose and see if the drug can shrink tumors. It is for pati…
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: EvolveImmune United, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
AI-Powered daily radiation adjustments aim to improve anal cancer treatment
Disease control Recruiting nowThis pilot study tests whether using artificial intelligence to adjust radiation plans daily can better target tumors while sparing healthy organs in people with locally advanced anal cancer. Twenty participants will receive standard radiation over six weeks, but each day's plan …
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Anal cancer patients may avoid groin radiation side effects
Disease control Recruiting nowThis study is for people with early-stage anal cancer. It tests whether skipping radiation to the groin (when scans and biopsies show no cancer there) works just as well as giving it, while causing fewer side effects and better quality of life. About 45 participants will receive …
Matched conditions: ANAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC